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Abstract
Background: Tuberculosis and smoking represent a major global health problem that is well recognized in the Republic of Moldova and worldwide. 
There is strong relationship between social vulnerability and psychotropic substance abuse: tobacco smoking, alcohol abuse and illicit drug use. The aim 
of the study was the impact assessment of active tobacco smoking and associated determinants on evolution of pulmonary tuberculosis and treatment 
outcome.
Material and methods: pulmonary TB patients diagnosed in the period 1.1.2014-31.12.2014 in Chisinau city were distributed in two groups: study 
group constituted 209 patients with pulmonary TB and active smoking and control group (CG) – 79 patients with pulmonary TB never-smokers.
Results: Risk factors for development of active TB at smokers are poverty-related conditions, male sex, single matrimonial status, medico-biological 
conditions and alcohol addiction, low educational status, urban residence. Case-management of smokers with pulmonary TB was worsened by the lack 
of health insurance (two thirds), late detection and epidemiological danger due to positive bacillary smear status. Co-morbidities and TB-related radio-
morphological features (bilateral localization, lung destructions, dissemination, and positive bacillary status) adjusted to risk factors contribute to low 
treatment outcome. 
Conclusions: Targeted interventions for smoking quitting in the frame of risk subgroups will diminish the rate of severe and complicated forms of 
TB and will increase success rate, strengthening TB control at the community level. 
Key words: tuberculosis, tobacco smoking, risk groups.
Introduction
Tuberculosis (TB) represents a major global health 
problem that is well recognized in the Republic of Mol-
dova (MDA) [3]. Annually are registered almost 10 mil-
lion new TB cases that in association with human immu-
nodeficiency virus represent a leading cause of death. In 
2014 were registered 5,4 million new cases among men, 3,2 
million cases among women and 1.0 million sick children 
worldwide. In addition to this in 2014 were registered 1,5 
million deaths due to tuberculosis, among them – 1,1 mil-
lion were HIV negative and 0,4 million were HIV-positive 
[15]. The Republic of Moldova shows a slow decreasing of 
disease prevalence during the period 2013-2015 with 3904 
TB patients in 2013, 3450 patients in 2014 and 3073 pa-
tients in 2015 [3]. The social determinants of TB are well 
recognised in MDA as well as worldwide . The continuous 
socio-economical, as well as, political crisis through which 
passes MDA determine the continuously increasing rate of 
socially vulnerable individuals [3]. It was defined a strong 
relationship between social vulnerability and psychotropic 
substance abuse: tobacco smoking, alcohol abuse and il-
licit drug use. Tobacco smoking is probably the most wide-
spread with the major socio-economic impact. Smoking is 
defined as an addictive disease of persons who reported 
smoking at least 100 cigarettes during their lifetime and 
who, at the time when they participated in the survey, re-
ported smoking every day or some days. About 1.1 billion 
people, that means one in every three adults, are smokers 
according to the World Health Organization [16]. World-
wide, tobacco smoking causes nearly 6 million deaths per 
year, and more than 8 million deaths annually are pre-
dicted by 2030 [6]. More than 160 million Americans are 
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living with tobacco addiction: 16.8% of all adults (40 mil-
lion people): 18.8% of males and 14.8% of females in the 
US are smokers. Cigarette smoking is responsible for more 
than 480.000 deaths per year in the US and 42.000 deaths 
resulting from environmental (second-hand smoke) expo-
sure [12]. According to the Demographic Study of Health 
in MDA in 2005 there were estimated 51,1% smoking men 
and 7,1% smoking women [10]. The prevalence of tobacco 
smoking is identified at 65% of general Moldovan adult 
population and Moldovan men are 4 times more predis-
posed to smoke than  women. The current data established 
that the tobaccco smoke represents the second cause of 
chronic morbidities among Moldovan men and the sev-
enth cause among women [10]. 
The chemical components of cigarette smoke depend 
on the structure of the cigarette and delivery way of the 
smoke. Most of the studies have reported the effects of the 
mainstream smoke and fewer identified effects of side-
stream and passive smoking [3]. The International Orga-
nization for Standardization expressed that the puff vol-
ume is 35 milliliters, for a two-second puff duration and 
butt length is 26 mm for filter cigarettes. When alternative 
smoking regimens (e-cigarette, cigar or pipe) are used, level 
of potentially harmful substances in smoke emission usu-
ally differs from those measured in standard conditions. 
Cigarette smoke is a complex of chemical compounds that 
are transformed in aerosol or in gas phase due to burning 
process. Smoke from a burning cigarette is a concentration 
of liquid particles suspended in the atmosphere consisting 
mainly of nitrogen, oxygen, carbon monooxide and carbon 
dioxid. Chemical tobacco compounds can be distilled into 
smoke or can react with other constituents and then dis-
tilled to smoke. It was estimated that cigarette smoke con-
tains 7.357 chemical components from different classes, 
including 20 carcinogenes (acrolein, formaldehyde, carbon 
monooxide, acealdehyde, phenol, potasium cianide, etc.) 
that cause cancer in laboratory animals and humans. The 
characterisitcs of the smoke vary due to cigarette design 
and chemical nature of the products: 1,3-butadiene ex-
poses the greatest potential risk for cancer development; 
acrolein and acetaldehyde is the most potential irritant for 
respiratory tract; cyanide, arsenic, and cresols are the pri-
mary causes for cardiovascular risk. The concentration of 
chemical compounds differs according to: the smoke for-
mation, the way through the cigarette is smoked and differ-
ences among cigarettes (tobacco type, tobacco preparation, 
the dimensions of the cigarettes, the weight of the tobacco 
rod, the porosity of the paper, the presence, type and the 
size of the filter) [5]. Mainstream smoke is released from 
the butt end of the burning cigarette during puffing. Side-
stream smoke is emanated from the burning cigarette coal. 
The air surrounding an active smoker contains a mixture 
of sidestream smoke, smoker’s exhaled mainstream smoke 
and smoke that passes the paper surounding the tobacco in 
burning. Toxic effects of the smoking are immediate, also 
called rapid toxic effects on the brain and are responsable 
for addictive power of nicotine. The initial increasing of 
dopamine activity due to nicotine inhalation determines 
the pleasant feelings for the smoker. The long anamnesis 
of smoking determines the reduction of dopamine recep-
tor function and decreasing the number of dopamine re-
ceptors, that causes to consume more cigarettes [7]. It was 
demonstrated that earlier starting of smoking alters the de-
velopment of the lung in adolescent period, limiting adult-
future breathing capacity and physical potential. The most 
expressed are immediate toxic effects of tobacco smoke on 
the respiratory system. Cigarette smoking conduces pri-
mary mucociliary transport alterations, expressed through 
reduction of mucociliary clearance, due to diminishing of 
the ciliary beat frequency and changes of mucus properties 
[6]. The chronic stress inflamation causes mucus metapla-
sia of the respiratory epithelium (starting with hyperplasia, 
then metaplasia with keratinization of epithelium), dimin-
ishes the viability of cells, induces apoptosis, increases the 
size of goblet cells and consequently stimulates the upper 
airway mucous secretions [1, 7]. Smoking interferes in cil-
iogenesis process, determining the alteration in matura-
tion and reduces the size of cilus, that predisposes bacterial 
colonization and infection of the respiratory tract. Airways 
of smokers are preferentially colonized by Gram negative 
bacteria, due to an increased resistance of Gram negative 
more than Gram positive microorganisms to the smoke, 
and due to an increased adhesion of microbs to epithelial 
cells. The exposure to high concentration of smoke stimu-
lates the formation of bacteria biofilms. The bacteria-epi-
thelium interaction causes the increased inflammatory re-
action of epithelium, that is not linked to the toxins of the 
smoke. Due to stress inflammation an acute bronchospam, 
increased phlegm production, disturbances in air-blood 
distribution in lungs. All identified alterations decrease 
physical performance of the smokers due to reduced me-
canical ventilation and decreased lung function.
Also the cigarette smoke determines cardiovascular 
toxic effects more relevant on the lipid profile, that may in-
crease risk of thrombosis, vasoconstriction and increased 
blood pressure. Nicotine consumption increases heart rate 
30 minutes after puffing. In association with a constantly 
increased blood pressure due to vasoconctriction the con-
gestive heart failure is ten times more frequently than in 
non-smokers [3].
Second-hand smoke, called also environmental smoke 
is considered more carcinogenic than the smoke of the 
mainstream inhaled by the active smoker. Because the 
cigarette burns at a lower temperature and much more 
amount of tobacco is pyrolised during smouldering (80% 
of cigarette burns between puffs), the sidestream smoke 
contains a higher amount of carcinogenes (more than 40 
of known), than the same volume of mainstream smoke: 
up to 50 times more formaldehyde, 3.5 times benzopyrene 
Curierul medical, October 2016, Vol. 59, No 5RESEARCH STUDIES
and 7.2 times cadmium. Hundreds of studies performed 
after 1980 identified the relationship between exposing to 
environmental tobacco smoke and lung, nasal cavity, head 
and neck, stomach, cervix, bladder cancers and leukemia. 
The risk of cancer depends on the way of smoking (passive 
and active smoking), measures of the individual exposure, 
populational exposure to passive smoking, residential and 
occupational exposure. For every person who dies because 
of smoking, at least 30 people live with serious-smoking 
related disease. More frequently associated diseases are dif-
ferent types of cancers, diseases of cardio-vascular system 
and suddden death, diabetes, respiratory diseases (chronic 
obstructive pulmonary disease, emphysema, bronchiec-
tasis) [9]. The tobacco smoking contributes to the devel-
opment of lung cancer, followed by oral, pharingeal and 
esophageal cancers, as well as tuberculosis [4].
The risk is increased by the lack of ventilation, indoor 
pollution, and depends on the room size, the number of 
persons who smoke, the number of smoked cigarettes. 
Chronic respiratory diseases (CRD), such as: chronic 
bronchitis, chronic obstructive pulmonary disease, small 
airways disease, pulmonary emphysema, lung fibrosis, 
bronchiectasis, chronic rhinosinusitis and chronic phar-
ingo-laringitis  are results of an active or environmental 
smoking (passive smoking) [1]. Acute bronchitis, com-
munity aquired pneumonia, asthma exacerbation, acute 
middle ear infection, acute nasal irritation, acute conjunc-
tivitis, and TB are more common in smokers than in non-
smokers [2]. There is a little variety of studies on vulner-
ability of smokers to active TB. The pathways that increase 
the vulnerability of the smoker to mycobacterial infection 
are: chronic alterations of epithelium, decreasing local im-
mune resistance, lower ability of smokers to maintain la-
tent mycobacterial infection, that increase the risk of active 
TB up to three times.
Research review identified that chronic exposure to to-
bacco and to environmental pollutants, impairs the clear-
ance of tracheo-bronchial secretions, as well as impairs 
the function of pulmonary alveolar macrophages. In vitro 
studies, determined that nicotine acts on acetiylcholine 
receptors of macrophages, that decreases the production 
of intracellular tumor necrosis factor (TNF-α) and impairs 
the killing of intracellular mycobacteria [7]. So, resulting 
deficiency in non-specific defense represents the main 
cause that contributes to the progression of active tubercu-
losis from latent TB infection [1].
It was identified a strong relationship between the du-
ratation of smoking and the severity of TB. In addition, 
active as well as passive smoking reduces the effectiveness 
of chemopreventive treatment and the effectiveness of TB 
treatment (the risk of death among smokers is six times 
higher than in non-smokers, and the risk of relapse is three 
times higher than in non-smokers). Much more data we 
need to investigate for establishing the impact of: the age at 
which smoking was started, the duration and the intensity 
of smoking (the number of smoked cigarettes), type of to-
bacco and the quality of cigarettes on the risk of active TB 
development [1].
A special attention is actually paid to second-hand 
smoke that affects children and adults, sharing the same 
house/place with smokers with active TB. The sick smok-
ers put their families at a greater risk for contracting my-
cobacterial infection and at a greater risk for active TB 
development [1]. Considering all related data, associated 
with unstable socioeconomical and epidemiological situa-
tion in MDA, as well as the large proportion of smokers in 
the general population it was identified the need for per-
forming a research about the health consequences and the 
impact of the smoking on active TB evolution and treat-
ment outcome. So, the aim of the study was the impact 
assessment of active tobacco smoking and associated de-
terminants on evolution of pulmonary tuberculosis and 
treartment outcome. Established objectives were:  1. As-
sessment of general, socio-economical and epidemiologi-
cal characteristics of active smokers with pulmonary TB; 
2. Evaluation of case-management, clinical aspects, radio-
logical aspects and treartment outcome of pulmonary TB 
at active smokers.
Material and methods
It was realised a retrospective and selective research of 
a study group (SG) consisting of 209 patients with pulmo-
nary TB and active smoking and control group (CG) – 79 
patients with pulmonary TB never-smokers, registered as 
a new case during the period 01.01.2014 to 31.12.2014. 
The patients’ medical records were assessed after being 
hospitalized in the Municipal Hospital of Tuberculosis 
of Chisinau, where the patients were investigated and re-
ceived TB treatment during the intensive phase. Including 
criteria in both groups were the diagnosis of new pulmo-
nary TB cases, new case (patients never treated for TB, 
or have taken anti-TB drugs less than one month), signed 
informed consent. Individual research chart included the 
points with such data: anamnesis, data of clinical exami-
nation, results of radiological investigations (chest radi-
ography, high resolution computer tomography), results 
of microbiological investigations (smear bacterioscopy at 
Ziehl-Neelson staining) and bacteriological examenations 
(culture on conventional solid medium Lowenstein-Jen-
sen and liquide BACTEC MGIT) [4]. Investigations were 
performed according to National Policy – Tuberculosis in 
Adults. Smoking behaviour questionnaire included the 
questions about the number of cigarettes smoked per day, 
the period of time of “smoking pack years”, type of smoked 
cigarettes (with or without filters). Statistical assessements 
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Results and discussions
Assessing current status of active smokers with pul-
monary TB it was established that only 28 (13,6%) were 
light smokers with less than 10 pack years. The majority 
[163 (79,13%) patients] were moderate smokers, being as-
sessed with 10-20 pack years and heavy smokers (more 
than 20 pack years) were 18 (8,7%) cases. The biggest 
part of SG [198 (96,1%) patients] smoked cigarettes with 
filter. Assessment of general, socioeconomical and med-
ico-biological characteristics of active smoking patients 
with pulmonary TB in comparison with never-smokers is 
shown in the table 1. Distributing patients by sex it was 
estbalished the predominance of male sex in comparison 
with female in both groups: 158 (76,6%) males in com-
parison with 48 females (23,4%) in SG and 48 (60,7%) 
males vs 31 (39,3%) females in CG. Comparing the groups 
it was established that the males predominated in SG 158 
(76,6%) vs 48 (60,7%) in CG. Females were more frequent 
in CG 48 (23,4%) than in SG 78 (98,7%) cases. Reparti-
tion of patients in age subgroups according to the WHO 
recommendations, identified that the largest subgroup in 
SG represented 25-34 year age group: 62 (30,1%) patients 
and in CG 35-44 year subgroup 78 (98,7%) patients. The 
younger group of patients aged 18-24 predominated in SG: 
46 (22,3%) vs 7 (8,8%) cases in CG. Redistributing patients 
in two subgroups aged 18-44 and >45 it was established 
the predominance of younger subgroup (18-44 years) in 
both SG and CG: 156 (75,7%) patients 67 (84,8%) cases, 
respectively.
Assessing the place of stable residence it was identi-
fied that patients from urban area were more frequently in 
SG [162 (78,6%) cases] than in CG [45 (56,9%) cases] and 
patients from rural area were more prevalent in CG [34 
(43,1%) cases] than in SG [44 (21,4%) cases]. Considering 
the educational level of selected patients it was determined 
that individuals with low level of school education (pri-
mary and incomplete secondary school) were identified in 
a similar proportion in both study and control groups: 123 
(59,7%) and 51 (64,5%) cases, respectively. Socioeconomic 
(employment) status was higher in CG than in SG. One 
third of patients were employed in CG [23 (29,1%) patients] 
and 25 (12,2%) cases in SG. Two thirds of patients were 
unemployed in SG [156 (75,73%) cases] and 48 (60,6%) 
patients in CG. Other socio-economical categories were 
in a similar proportion, but the totality of economically 
disabled patients, that included all non-economically pro-
ductive patients (unemployed, retired and students) statis-
ticaly prevaled in SG: 181 (87,86%) vs 46 (58,23%) cases in 
CG. Considering the high rate of economically defavorised 
patients in both groups, the tobacco smoking worsens the 
financial state, predisposing the development of TB. Ap-
preciating the civil status it was identified more frequently 
married persons in CG [51 (64,5%) cases] than in SG [84 
(40,7%) cases] and single state individuals predominated 
in SG: 122 (59,3%) vs 28 (35,5%) cases in CG. Poor life 
conditions considered as under the minimum consumer 
basket predominated in SG: 123 (59,8%) vs 32 (40,5%) pa-
tients in CG. Although smoking is a leading cause of mor-
bidity and mortality worldwide, it is not recognised as a 
disease by itself. Considering nicotine, the component of 
tobacco an addictive drug regulating the feelings of plea-
sure, in most cases the desire to smoke is combined with 
the consumption of other drugs such as alcohol or illicit 
drugs. Alcohol is the second most used addictive substance 
in the world, after tobacco smoking. Chronic alcoholism, 
as well as binge drinking and heavy drinking is 10 times 
more frequent at tobacco smokers than among nonsmok-
Tabel 1




SG,  n=206 CG, n=79 P 
value
n (%) n (%)
Sex Men 158 (76,6) 48 (60,7) <0,01




18-24 years 46 (22,3) 7 (8,8) <0,01
25 – 34 years 62 (30,1) 24 (30,4) >0,05
35-44 years 48 (23,3) 78 (98,7) <0,001
>45 years old 45-54 years 38 (18,5) 10 (12,6) >0,05
>55years 15 (7,28) 2 (2,5) >0,05
Residence Urban 162 (78,6) 45 (56,9) <0,001





















Disabled 8 (3,8) 5 (6,3) >0,05
Students 2 (0,9) 1 (1,3) >0,05
Retired 15 (7,3) 2 (2,5) >0,05
Civil status Married 84 (40,7) 51 (64,5) <0,001
Single 117 (56,8) 25 (31,6) <0,001
Divorced&widow 5 (2,43) 3 (3,7) >0,05





Migration 28 (13,6) 10 (12,6) >0,05
Alcohol abuse 111 (53,8) 3 (3,8) <0,001
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ers. Alcohol abuse and chronic alcoholism were identified 
at one half of smokers and only at a couple of non-smoking 
patients. Illicit drug use was identified only in SG.  History 
of emprisonment was identified at a lower rate in SG. In 
this context it is important to note a very low rate of fam-
ily TB clusters [24 (11,6%) cases] affiliated to each inves-
tigated patient. It is due to a low quality epidemiological 
cross-examination of the patient, rather than to the lack of 
close (family) contacts in the patient’s environment. 
Associated diseases were identified at one half of pa-
tients from both groups. No neoplastic diseases were iden-
tified at the selected patients. The effect of associated dis-
orders or diseases is important because they endanger the 
TB treatment effectiveness. If the clinical state of the pa-
tient is not so worsened the TB treatment might be started 
primarily, subsequent treatment for underlined diseases 
will be performed when the clinical tolerance to the TB 
treatment is established (TB/HIV infection). One third 
of patients was identified with one comorbidity in both 
groups [59 (28,6%) cases in SG and 18 (22,78%) cases in 
CG]. There was not found a statistical difference between 
groups counting diagnosis clusters, except the group of 
chronic respiratory diseases, that predominated in the SG: 
42 (20,4%) patients in comparision with 9 (11,4%) patients 
from CG. More patients from CG had gastrointestinal, dia-
betes mellitus, chronic renal diseases, but was not found a 
statistical difference between groups.
Studying case-management, diagnosis delay, medi-
cal staff involved in the patient’s detection and clinical-
radiological diagnosis it was established that three fourths 
of patients from SG exposed as a barrier for health care 
seeking the lack of health insurance comparing with only 
one half of CG. Delayed case detection, that means more 
than 60 days after the disease onset was registered more 
often in patients from the SG (two thirds) and only one 
third in CG. According to the actual recommendations the 
main way for new case detection is the microscopic ex-
amination of the symptomatic patients associated with the 
smear genetic test through GeneXpert MTB/Rif assay. So, 
two thirds of all selected patients were detected by the gen-
eral practitioner due to specific symptomatology (passive 
way of case detection): 152 (73,7%) patients from SG and 
52 (65,8%) patients from CG. One fifth of patients of both 
groups were detected by the specialist (pneumophtysiolo-
gist) and a fewer rate were detected otherwise (by transfer 
from other medical institutions, investigation by other spe-
cialists, detected in the frame of investigations performed 
for the work engagement).
Assessing laboratory features of pulmonary TB it was 
identified that one half of smokers were microscopic posi-
tive for acid-fast-bacilli and only a fewer part of the CG. So, 
the first criteria that defined the highest epidemiological 
danger of TB clusters was identified in one half of patients 
from SG. Infiltrates localized in both lungs were more fre-
quently identified in SG [131 (63,6%) patients] compar-
ing with infiltrates identified only in one lung, which were 
more frequently identified in CG 54 (26,2%). Evaluating 
radio-morphological features of pulmonary TB, were iden-
tified lung infiltrates complicated with destructions at 131 
(63,6%) cases of SG and only at 18 (22,8%) patients from 
CG. Lung dissemination (through bronchogenic and lym-
phogenic ways) was established only in SG [28 (13,6%) pa-
tients]. Complications (such as hemoptysis, pneumotho-
rax, pleurisy) occurred more often in the SG [59 (28,6%) 
cases] than in CG. Patients were informed about the fact 
that smoking cessation will improve treatment outcome, 
but no other psychological interventions and quitting 
replacement therapy were performed. A little rate of pa-
tients discontinued smoking due to increasing dyspnea. 
Treatment outcome convincingly established the impact 
of tobacco smoking on disease outcome. The highest rate 
of patients succesfully finished the standard treatment 
Table 2
Case-management and pulmonary TB features
Characteristics
n (%)




Lack of health insurance 162 (78,6) 45 (56,9) <0,001
Associated diseases 123 (59,7) 36 (45,6) >0,05
Late detected (>60 days) 131 (63,6) 28 (35,4) <0,001
Detected by general practitioner way 152 (73,7) 52 (65,8) >0,05
Detected by pneumophtysiologist 31 (15,0) 18 (22,7) >0,05
Other ways of detection 23 (11,1) 9 (11,4) >0,05
Para-clinical
features
Microscopic positive 121 (58,7) 12 (15,2) <0,001
1 lung involved 54 (26,2) 58 (73,4) <0,001
2 lungs involved 152 (73,7) 21 (26,6) <0,001
Lung destructions 131 (63,6) 18 (22,8) <0,001
Dissemination (bronchogenic, lymphogenic) 28 (13,6) 0 <0,001
Complications 59 (28,6) 3 (3,8%) <0,001
23
24
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according to WHO recommendations in CG: 76 (96,21%) 
vs 142 (68,9%) patients from SG. No deaths were registred 
in CG and 16 (7,67%) cases in SG. Patients that failed the 
standard treatment or those who were lost from follow-
up predominated in patients from SG: 48 (23,31%) vs 3 
(3,89%) patients of CG.
An important research outcome represents the relative 
risk (RR), odds ratio (OR) and attribuitable risk (AR) indi-
ces for identifying the priority interventions in the frame of 
specific subgroups. All indices demonstrated the risk im-
pact of causal factor-tobacco smoking on TB development. 
There were selected only risk factors and features which 
exposed statistical differences between groups of patiens.
Calculating relative risk index it was established that 
all exposed conditions are associated with tobacco smok-
ing. Odds ratio identified that major risk factors associated 
with tobacco smoking are alcohol abuse and TB-related 
characteristics: dissemination, complications due to TB, 
pathological process localised in both lungs, bacillary TB 
(smear positive for acid fast bacilli), lung destructions. It 
was establshed that preventive advantages of smoking ces-
sation will be obtained especially on diminishing the rate 
of patients with lung dissemination and destructions, in-
volvement of both lungs in the pathological process, asso-
ciated complications (hemoptysis, pneumothorax, pleuri-
sy), epidemiological danger (bacillary forms of pulmonary 
TB). In addition such associated determinants will be 
substantially reduced by smoking cessation: alcohol abuse 
and single civil state. A lower impact will be achieved by 
poverty-related features and residence.
Conclusions
Tuberculosis is a big challenge worldwide, in addition 
active smokers are the most widely expressed risk group 
for active disease.
Risk factors for the development of active tuberculosis 
at smokers are: poverty-related conditions, male sex, single 
matrimonial status, medico-biological conditions and al-
cohol addiction, low educational status, urban residence.
One half of smoking group with TB patients was estab-
lished with positive bacillary status at smear microscopy.
Delayed case-management of active smokers with pul-
monary TB was determined by the lack of health insur-
ance in the frame of primary health care sector. Comor-
bidities and disease-related radio-morphological features 
(bilateral localization, lung destructions, dissemination, 
positive bacillary status) associated with enumerated risk 
factors contibute to low treatment outcome. Targeted in-
terventions for smoking quitting in the frame of risk sub-
groups will diminish the rate of severe and complicated 
forms of TB and will increase the rate of treatment success, 
strenghthening TB control at the community level. 
Raising awareness among smokers and their families 
about TB, emphasizing that the diagnosis and treatment 
is free of charge and independent regarding their social 
status will improve epidemiological state. Improvement of 
the socio-economical and hygienic conditions, associated 
with quitting drug therapy and psychological counseling 
will diminish the risk for TB development among smok-
ers. Maintaining the active smokers as a part of high risk 
groups for the screenng to TB will diminish the rate of se-
vere TB forms and the burden of smoking-related disease.
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